Although previous studies have attributed positive immune responses to PD-L1 staining, tumor mutational burden (TMB), and microsatellite instability (MSI) in many tumors, it does not apply to HCC (175–178). This evidence concerns the gene CD274 and hepatocellular carcinoma.